Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 74
1988 162
1989 220
1990 259
1991 330
1992 330
1993 418
1994 457
1995 610
1996 628
1997 686
1998 774
1999 917
2000 780
2001 897
2002 962
2003 975
2004 1009
2005 846
2006 1109
2007 1128
2008 846
2009 579
2010 779
2011 822
2012 1001
2013 1137
2014 1035
2015 993
2016 904
2017 773
2018 687
2019 712
2020 186
Text availability
Article attribute
Article type
Publication date

Search Results

19,918 results
Results by year
Filters applied: . Clear all
Page 1
Control of mTOR signaling by ubiquitin
Jiang Y, et al. Oncogene 2019 - Review. PMID 30705402 Free PMC article.
SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation.
Gomez ML, et al. Oncogene 2019. PMID 31222103 Free PMC article.
In the same cells, decrease in SOD1 is associated with an elevation in both apoptosis as well as oncogene-induced senescence. Based on these results, we suggest that SOD1 carries a housekeeping function that maintains ROS levels below a threshold that supports oncogene-dependent proliferation, while allowing escape from oncogene-induced senescence, independently of the oncogene driving tumor formation. ...
In the same cells, decrease in SOD1 is associated with an elevation in both apoptosis as well as oncogene-induced senescence. Based o …
Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis
Tiemann K, et al. Oncogene 2019. PMID 30575818
AGR2 has also been characterized as a proto-oncogene and a potential cancer biomarker. Cellular localization of AGR2 is emerging as a key component for understanding the role of AGR2 as a proto-oncogene. ...
AGR2 has also been characterized as a proto-oncogene and a potential cancer biomarker. Cellular localization of AGR2 is emerging as a …
miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma.
Cui T, et al. Oncogene 2019. PMID 30559405 Free PMC article.
Taken together, our data suggest that miR-4516 represents an independent negative prognostic factor in GBM patients and acts as a novel oncogene in GBM, which regulates the PTPN14/Hippo pathway. ...
Taken together, our data suggest that miR-4516 represents an independent negative prognostic factor in GBM patients and acts as a novel o
19,918 results
Jump to page
Feedback